News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,027 Results
Type
Article (42938)
Company Profile (272)
Press Release (684806)
Multimedia
Podcasts (81)
Webinars (18)
Section
Business (205935)
Career Advice (2191)
Deals (35691)
Drug Delivery (112)
Drug Development (81980)
Employer Resources (176)
FDA (16562)
Job Trends (15067)
News (348729)
Policy (32992)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2628)
Accelerated approval (32)
Adcomms (25)
Allergies (139)
Alliances (50078)
ALS (172)
Alzheimer's disease (1675)
Antibody-drug conjugate (ADC) (306)
Approvals (16813)
Artificial intelligence (515)
Autoimmune disease (145)
Automation (38)
Bankruptcy (362)
Best Places to Work (11734)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (177)
Bladder cancer (159)
Brain cancer (55)
Breast cancer (640)
Cancer (4803)
Cardiovascular disease (397)
Career advice (1848)
Career pathing (37)
CAR-T (279)
CDC (45)
Celiac Disease (2)
Cell therapy (737)
Cervical cancer (36)
Clinical research (69911)
Collaboration (1690)
Company closure (4)
Compensation (1138)
Complete response letters (54)
COVID-19 (2744)
CRISPR (89)
C-suite (822)
Cystic fibrosis (143)
Data (6173)
Decentralized trials (2)
Denatured (26)
Depression (132)
Diabetes (496)
Diagnostics (6767)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (244)
Drug pricing (188)
Drug shortages (28)
Duchenne muscular dystrophy (227)
Earnings (90181)
Editorial (56)
Employer branding (22)
Employer resources (155)
Events (117849)
Executive appointments (972)
FDA (19651)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1465)
Gene editing (194)
Generative AI (44)
Gene therapy (595)
GLP-1 (976)
Government (4701)
Grass and pollen (6)
Guidances (383)
Healthcare (19104)
HIV (56)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (249)
Immuno-oncology (55)
Indications (103)
Infectious disease (3004)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (244)
Interviews (358)
IPO (16675)
IRA (49)
Job creations (3670)
Job search strategy (1540)
JPM (58)
Kidney cancer (16)
Labor market (83)
Layoffs (554)
Leadership (33)
Legal (8000)
Liver cancer (91)
Longevity (14)
Lung cancer (643)
Lymphoma (372)
Machine learning (42)
Management (61)
Manufacturing (788)
MASH (161)
Medical device (13885)
Medtech (13938)
Mergers & acquisitions (20078)
Metabolic disorders (1255)
Multiple sclerosis (157)
NASH (16)
Neurodegenerative disease (314)
Neuropsychiatric disorders (87)
Neuroscience (2897)
Neurotech (1)
NextGen: Class of 2026 (6630)
Non-profit (4575)
Now hiring (65)
Obesity (589)
Opinion (267)
Ovarian cancer (165)
Pain (198)
Pancreatic cancer (223)
Parkinson's disease (281)
Partnered (33)
Patents (489)
Patient recruitment (473)
Peanut (56)
People (59269)
Pharmaceutical (63)
Pharmacy benefit managers (30)
Phase 1 (21818)
Phase 2 (30763)
Phase 3 (22918)
Pipeline (5095)
Policy (281)
Postmarket research (2583)
Preclinical (9309)
Press Release (66)
Prostate cancer (236)
Psychedelics (47)
Radiopharmaceuticals (281)
Rare diseases (822)
Real estate (6008)
Recruiting (70)
Regulatory (24618)
Reports (51)
Research institute (2445)
Resumes & cover letters (369)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (147)
Series A (239)
Series B (187)
Service/supplier (11)
Sickle cell disease (95)
Special edition (22)
Spinal muscular atrophy (160)
Sponsored (42)
Startups (3662)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (86)
The Weekly (53)
Vaccines (997)
Venture capital (89)
Weight loss (379)
Women's health (87)
Worklife (19)
Date
Last 7 days (595)
Last 30 days (2076)
Last 365 days (29954)
2026 (2832)
2025 (30404)
2024 (35452)
2023 (40369)
2022 (51524)
2021 (56085)
2020 (54530)
2019 (47089)
2018 (35438)
2017 (32466)
2016 (31902)
2015 (37986)
2014 (31654)
2013 (26710)
2012 (28921)
2011 (29557)
2010 (27603)
Location
Africa (763)
Alabama (84)
Alaska (7)
Arizona (307)
Arkansas (13)
Asia (39651)
Australia (6546)
California (11190)
Canada (3262)
China (1087)
Colorado (475)
Connecticut (473)
Delaware (334)
Europe (85990)
Florida (1668)
Georgia (354)
Hawaii (3)
Idaho (62)
Illinois (858)
India (63)
Indiana (517)
Iowa (23)
Japan (417)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1379)
Massachusetts (8036)
Michigan (320)
Minnesota (626)
Mississippi (5)
Missouri (126)
Montana (32)
Nebraska (28)
Nevada (123)
New Hampshire (79)
New Jersey (2972)
New Mexico (30)
New York (2964)
North Carolina (1445)
North Dakota (9)
Northern California (5449)
Ohio (332)
Oklahoma (21)
Oregon (42)
Pennsylvania (2256)
Puerto Rico (22)
Rhode Island (47)
South America (1131)
South Carolina (65)
South Dakota (1)
Southern California (4354)
Tennessee (174)
Texas (1727)
United States (39741)
Utah (333)
Vermont (1)
Virginia (259)
Washington D.C. (81)
Washington State (918)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
728,027 Results for "trace ability inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Trace Biosciences Announces FDA IND Clearance for First Nerve-Specific Imaging Agent
February 2, 2026
·
3 min read
Press Releases
Ability Biotherapeutics Appoints Angèle Maki, PhD, as Chief Business Officer
December 10, 2025
·
3 min read
Press Releases
Tubulis Unveils Alco5 Conjugation Platform’s Ability to Expand ADC Payload Scope in Nature Communications
January 21, 2026
·
3 min read
Press Releases
Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial
April 1, 2025
·
3 min read
Genetown
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats.
March 12, 2024
·
5 min read
Press Releases
CorriXR Therapeutics Announces Publication of Additional Preclinical Data Corroborating Ability of NRF2 Knockout to Restore Chemosensitivity in Solid Tumors
January 23, 2026
·
4 min read
Press Releases
Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib’s Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+
December 10, 2025
·
9 min read
Press Releases
Ability Biotherapeutics Expands its Scientific Advisory Board with the Appointment of Dr. John Burke and Dr. Alan Korman
November 20, 2025
·
3 min read
Press Releases
New Data Underscoring Ability of Leapfrog Bio’s OncoSLX Platform to Identify Drug Retargeting Opportunities for Treating Cancer Published in Nature Portfolio Journal
January 12, 2026
·
4 min read
Press Releases
Actio Biosciences Announces Preclinical Data Highlighting Ability of ABS-1230 to Potently and Selectively Inhibit KCNT1 and Significantly Reduce Seizure Activity
December 8, 2025
·
4 min read
1 of 72,803
Next
